• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
×
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
      • Methods Guide for Clinical Equipment and Devices
      • Guidance Document for the Use of Real-World Evidence
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • HTA Topic Priority Lists
      • HTA TOPIC PRIORITY LIST (Cycle 1)
      • HTA TOPIC PRIORITY LIST (Cycle 2)
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
  • AUXILIARY MENU
Menu
GOVPH
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
      • Methods Guide for Clinical Equipment and Devices
      • Guidance Document for the Use of Real-World Evidence
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • Road to HTA Institutionalization
    • External Partners
  • Publications
    • Omnibus HTA Tracker
    • HTA Topic Priority Lists
      • HTA TOPIC PRIORITY LIST (Cycle 1)
      • HTA TOPIC PRIORITY LIST (Cycle 2)
    • Assessments
    • Evidence Briefs
    • Issuances
    • Events and Press Releases
    • Annual Reports
      • 2023 Annual Report
      • 2022 Annual Report
      • 2021 Annual Report
      • 2020 Annual Report
      • 2019 Annual Report
    • FAQs on HTA
  • Get Involved with Us
    • Topic Nomination
    • Call for Proposals
    • Appeals
    • Careers
    • Contact Us
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer
    • Default Text Size
    • Reduce Text Size - -
    • Enlarge Text Size + +

DOST - Health Technology Assessment Official Logo
Republic of the Philippines
DOST - Health Technology Assessment

Philippine Standard Time:

[Department Circular No. 2021- 0331] The Health Technology Assessment Council (HTAC) Releases Its Updated Evidence Summaries for COVID-19 Vaccine Assessments

Posted on August 17, 2021

MEMORANDUM- Request for Comments on Evaluation Framework for COVID-19 Vaccines (Version 2)

Posted on August 16, 2021

HTAC Evaluation Framework for COVID-19 Vaccines 2022 link:  bit.ly/HTAC-C19EvalFramework_Version2 Document preview:

Evidence brief for 07 August to 13 August 2021

Posted on August 13, 2021

For the period of  07 August to 13 August 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU)     Document Link: 07 August to 13 August 2021

[Department Circular No. 2021- 0348] Coresia Vaccine Certificate Survey for Key Stakeholders

Posted on August 10, 2021

Preliminary Recommendation on Tenofovir/Lamivudine/Dolutegravir (TLD)

Posted on August 9, 2021

Document link: MEDICINES RECOMMENDED FOR INCLUSION IN THE PHILIPPINE NATIONAL FORMULARY (PNF) (Proponents may submit appeals to hta@doh.gov.ph until 23 August 2021.) Document Preview:

Post navigation

← Older posts
Newer posts →